Cardiac tissue engineering: state of the art. Circ Res. 2014;114(2):354-67..
Human engineered heart tissue as a model system for drug testing. Adv Drug Deliv Rev. 2015..
Satellite cells delivered in their niche efficiently generate functional myotubes in three-dimensional cell culture. PLoS One. 2018;13(9):e0202574..
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO Mol Med. 2019:e11115.
Dissecting hiPSC-CM pacemaker function in a cardiac organoid model. Biomaterials. 2019;206:133-145..
Heart Repair With Myocytes. Circ Res. 2019;124(6):843-845..
Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism. Biochim Biophys Acta Mol Cell Res. 2019..
Intermittent optogenetic tachypacing of atrial engineered heart tissue induces only limited electrical remodelling. J Cardiovasc Pharmacol. 2020..
Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes. Cell Rep. 2020;32(3):107925.
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res. 2020.
Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy. Stem Cell Res. 2021;55:102489.
Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue. J Mol Cell Cardiol. 2021..
Sulforaphane exposure impairs contractility and mitochondrial function in three-dimensional engineered heart tissue. Redox Biol. 2021;41:101951.
Translational investigation of electrophysiology in hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2021.